Albemarle Corp diskutieren
Albemarle Corp
WKN: 890167 / Symbol: ALB / Name: Albemarle / Aktie / Chemie / Mid Cap /
79,79 €
0,20 %
Buy Albemarle Corp
Sell Albemarle Corp
Sell Albemarle Corp
Buy beendet
Sell beendet
Sell beendet
Buy Albemarle Corp
Sell Albemarle Corp
Sell Albemarle Corp
Buy Albemarle Corp
Albemarle Co. (NYSE: ALB) was upgraded by analysts at Scotiabank from a "sector perform" rating to an "outperform" rating.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock, up previously from $196.00.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target raised by analysts at Wells Fargo & Company from $250.00 to $270.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Wells Fargo & Company from $270.00 to $260.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target raised by analysts at Royal Bank of Canada from $255.00 to $260.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Evercore ISI from $295.00 to $280.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at KeyCorp from $291.00 to $254.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Citigroup Inc. from $265.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Wells Fargo & Company from $260.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Co. (NYSE: ALB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $260.00 price target on the stock.
Ratings data for ALB provided by MarketBeat
Neueste Beiträge
BTIG_Research in Integra LifeSciences Holdings Corp diskutieren